查看購物車
  • Simplified Chinese
  • English
細胞和基因治療合約開發和製造組織市場規模及預測 2021 - 2031、全球和區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按服務類型、產品類型、最終用戶和地理分類
市場調查報告書
商品編碼
1761163

細胞和基因治療合約開發和製造組織市場規模及預測 2021 - 2031、全球和區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按服務類型、產品類型、最終用戶和地理分類

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 249 Pages | 訂單完成後即時交付

價格

根據我們最新的研究報告《細胞和基因治療合約開發與製造組織市場預測（2031年）—全球分析—按服務類型、產品類型、最終用戶和地理分類》，預計該市場規模將從2024年的62.2億美元成長到2031年的318.6億美元；預計2025-2031年期間的複合年成長率為2025-2031年。創新療法臨床試驗的增加以及法規核准和商業化的激增，正在推動細胞和基因治療合約開發與製造組織市場規模的不斷成長。然而，製造環節的高複雜性阻礙了細胞和基因治療合約開發與製造組織市場的成長。此外，人工智慧和數位轉型的不斷融合預計將在未來幾年帶來新的細胞和基因治療合約開發與製造組織市場趨勢。

就收入而言，北美在 2024 年佔據市場主導地位。預計在預測期內，它將佔據全球市場主導地位。美國是世界上最大的細胞和基因治療合約開發和製造組織市場。美國正在經歷生物技術的不斷進步、遺傳疾病的日益普及以及對專業製造服務的需求激增。根據美國政府責任署 2021 年 10 月發布的估計，該國約有 2,500 萬至 3,000 萬人患有罕見疾病。根據美國食品藥物管理局 (FDA) 的數據，超過 7,000 種罕見疾病影響著全國超過 3,000 萬人。對這些疾病的了解日益加深導致基因治療發展的激增。 CDMO 透過為針對罕見遺傳疾病的基因療法的開發和製造提供專業服務，在這一領域發揮著至關重要的作用。

2023年，美國FDA批准了許多細胞和基因療法，包括針對罕見疾病的基因編輯療法。用於治療鐮狀細胞疾病的exagamglogene autotemcel（Casgevy）和lovotibeglogene autotemcel，以及用於治療重症血友病A的valoctocogene roxaparvovec等療法均已獲得FDA批准，凸顯了基因療法在應對罕見疾病挑戰方面的潛力。再生醫學先進療法（RMAT）認證等加速的監管途徑，促使生物技術公司與CDMO合作，以擴大生產規模。

製造業基礎設施的投資促進了市場的成長。由15家學術機構、超過25家公司和政府機構合作成立的國家細胞製造聯盟 (National Cell Manufacturing Consortium) 旨在實現細胞療法的經濟高效、大規模生產。此外，CDMO、學術機構和生物製藥公司之間的策略合作也促進了市場的成長。

細胞和基因治療合約開發和製造組織市場分析

獲得專業設施和技術，為未來提供市場機會

細胞和基因療法的需求正推動生物製藥公司尋求能夠提供尖端設施和技術的CDMO，這些設施和技術是擴大生產規模、確保品質、合規性和獲得監管批准的必要條件。這些專業能力對於複雜和個人化療法的生產至關重要，而這些療法需要先進的基礎設施來維持高生產標準。細胞和基因療法，包括基因編輯、病毒載體生產和個人化醫療，需要配備最新技術的專業設施。基因療法中使用的病毒載體的生產需要符合GMP標準的設施，以確保最終產品的安全性、一致性和品質。這些設施應能夠在受控和監控的環境中處理複雜的生物材料，例如活細胞和基因改造生物。自動化細胞培養系統、連續生產和數位化品質監控系統的日益普及，提高了基因療法生產的成長和效率。例如，2025年3月，Bharat Biotech公司在印度南部投資7,500萬美元建立了其首個細胞和基因治療設施，預計在未來3年內推出針對腫瘤和罕見疾病的新療法。

對專業設施的需求為CDMO創造了巨大的機會。對於生物製藥公司來說，與擁有所需技術和設施的CDMO合作既經濟高效，又能節省成本。例如，2023年，百時美施貴寶與CDMO合作生產其CAR-T細胞療法Breyanzi。此療法涉及採集、改造和擴增患者的T細胞，此過程需要專業的技術和設施才能確保達到預期的治療效果。透過利用CDMO在專業設施方面的專業知識，百時美施貴寶得以在確保合規性和品質的同時擴大生產規模。因此，對先進製​​造能力和先進技術的不斷成長的需求預計將為細胞和基因治療合約研發組織市場創造未來的成長機會。

細胞和基因治療合約開發和製造組織市場報告細分分析

有助於得出細胞和基因治療合約開發和製造組織市場分析的關鍵部分是服務類型、產品類型和最終用戶。

根據服務類型，細胞和基因治療合約開發與製造組織市場細分為藥物開發與製造、檢測與監管服務以及其他服務。藥物開發與製造領域在2024年佔據了最大的市場。

就產品類型而言，細胞和基因治療合約開發與製造組織市場分為基因治療和細胞治療。 2024年，細胞治療領域佔據市場主導地位。

根據最終用戶，細胞和基因治療合約開發與製造組織市場可分為製藥公司、生物製藥公司和其他公司。 2024年，生物製藥公司佔據了市場主導地位。

細胞和基因治療合約開發和製造組織市場：競爭格局和關鍵發展

藥明生物技術有限公司、Charles River Laboratories International Inc、Catalent Inc、Lonza Group AG、賽默飛世爾科技公司、AGC Biologics AS、Takara Bio Inc、富士膠片控股公司、Pluri Inc、SK pharmteco Inc、Aenova Holding GmbH 和 Minaris Advanced Therapies 是細胞和基因治療合約開發和製造組織市場的主要開發公司。

加拿大統計局、世界人口展望、Globocan、巴西衛生監管機構 (ANVISA)、再生醫學聯盟 (ARM) 和食品藥物管理局 (FDA) 是編寫細胞和基因治療合約開發和製造組織市場報告時參考的主要和次要來源。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：細胞和基因治療合約開發和製造組織市場格局

  • 概述
  • 全球質粒製造市場

第5章：細胞和基因治療合約開發和製造組織市場-關鍵市場動態

  • 細胞和基因治療合約開發和製造組織市場-關鍵市場動態
  • 市場促進因素
    • 增加創新療法的臨床試驗
    • 法規核准和商業化激增
  • 市場限制
    • 製造複雜性高
  • 市場機會
    • 使用專業設施和技術
  • 未來趨勢
    • 人工智慧與數位轉型日益融合
  • 促進因素和限制因素的影響：

第6章：細胞和基因治療合約開發和製造組織市場-全球市場分析

  • 細胞和基因治療合約開發和製造組織市場收入（2021-2031）
  • 細胞和基因治療合約開發和製造組織市場預測分析

第7章：細胞和基因治療合約開發和製造組織市場分析-按服務類型

  • 藥物開發與製造
  • 測試和監管服務
  • 其他

第8章：細胞和基因治療合約開發和製造組織市場分析-按產品類型

  • 基因治療
  • 細胞療法

第9章：細胞和基因治療合約開發和製造組織市場分析—按最終用戶

  • 製藥公司
  • 生物製藥公司
  • 其他

第 10 章：細胞和基因治療合約開發和製造組織市場-地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：競爭格局

  • 2024年全球公司市佔率分析

第 12 章：產業格局

  • 概述
  • 擴張
  • 新產品開發
  • 合併與收購
  • 合作夥伴關係
  • 其他商業策略

第13章：公司簡介

  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • Pluri Inc
  • SK pharmteco Inc
  • Aenova Holding GmbH
  • Minaris Advanced Therapies

第 14 章：附錄

Product Code: TIPRE00040769

According to our new research study on "Cell and Gene Therapy Contract Development and Manufacturing Organization Market Forecast to 2031 -Global Analysis - by Service Type, Product Type, End User, and Geography," the market is anticipated to grow from US$ 6.22 billion in 2024 and is projected to reach US$ 31.86 billion by 2031; it is expected to register a CAGR of 26.4% during 2025-2031. Increasing clinical trials for innovative therapies and surging regulatory approvals and commercialization are contributing to the growing cell and gene therapy contract development and manufacturing organization market size. However, the high manufacturing complexities hampers the cell and gene therapy contract development and manufacturing organization market growth. Further, rising integration of AI and digital transformation is expected to bring in new cell and gene therapy contract development and manufacturing organization market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for cell and gene therapy contract development and manufacturing organization in the world. The US is observing growing advancements in biotechnology, an increasing prevalence of genetic diseases, and surging demand for specialized manufacturing services. As per the estimates of the US Government Accountability Office published in October 2021, ~25 to 30 million people suffer from rare diseases in the country. As per the Food and Drug Administration (FDA), more than 7,000 rare diseases affect over 30 million people in the country. The growing understanding of these diseases has led to a surge in gene therapy development. CDMOs play a crucial role in this space by providing specialized services for the development and manufacturing of gene therapies targeting rare genetic disorders.

In 2023, the US FDA approved numerous cell and gene therapies, including gene-editing treatments targeting rare diseases. Therapies such as exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel for sickle cell disease, as well as valoctocogene roxaparvovec for severe hemophilia A, have received FDA approval, highlighting the potential of gene therapies in addressing rare disease challenges. The accelerated regulatory pathways, such as the Regenerative Medicine Advanced Therapy (RMAT) designation, have spurred biotechnology companies to partner with CDMOs for scaling production.

Investments in manufacturing infrastructure have bolstered the market growth. The National Cell Manufacturing Consortium, established through collaboration between 15 academic institutes, over 25 companies, and government agencies, aims to enable cost-effective, large-scale manufacturing of cell therapies. In addition, strategic collaborations between CDMOs, academic institutions, and biopharma companies also contribute to market growth.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis

Access to Specialized Facilities and Technologies to Provide Market Opportunities in Future

The demand for cell and gene therapies is driving biopharmaceutical companies toward CDMOs that can provide cutting-edge facilities and technologies, which are required to scale up production while ensuring quality, compliance, and regulatory approval. These specialized capabilities are essential for the production of complex and personalized therapies, which require advanced infrastructure to maintain high manufacturing standards. Cell and gene therapies, including gene editing, viral vector production, and personalized medicine, require specialized facilities equipped with the latest technologies. The production of viral vectors used in gene therapies requires GMP standard facilities to ensure the safety, consistency, and quality of the final product. These facilities should be equipped to handle complex biological materials, such as live cells and genetically modified organisms, in controlled and monitored environments. The increasing adoption of automated cell culture systems, continuous manufacturing, and digital quality monitoring systems enhances the growth and efficiency of gene therapy production. For instance, in March 2025, Bharat Biotech invested US$ 75 million in its first cell and gene therapy facility in the southern India which is expected to launch new therapies in next 3 years for oncology and rare disease.

The need for specialized facilities creates a substantial opportunity for CDMOs. It is cost-effective and efficient for biopharma companies to collaborate with CDMOs that have the required technology and facilities. For instance, in 2023, Bristol-Myers Squibb collaborated with a CDMO for the production of its CAR-T cell therapy, Breyanzi. This therapy involves harvesting, modifying, and expanding a patient's T-cells, a process requiring specialized technology and facilities to ensure the desired therapeutic effect. By leveraging CDMO expertise in specialized facilities, Bristol-Myers Squibb was able to scale production while ensuring regulatory compliance and quality. Thus, the soaring need for advanced manufacturing capabilities with advanced technology is expected to create future growth opportunities for the cell and gene therapy contract research and development organization market.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Report Segmentation Analysis

Key segments that contributed to the derivation of the cell and gene therapy contract development and manufacturing organization market analysis are service type, product type, and end user.

Based on service type, the cell and gene therapy contract development and manufacturing organization market is segmented into drug development and manufacturing, testing and regulatory services, and others. The drug development and manufacturing segment held the largest share of the market in 2024.

In terms of product type, the cell and gene therapy contract development and manufacturing organization market is bifurcated into gene therapy and cell therapy. The cell therapy segment dominated the market in 2024.

By end user, the cell and gene therapy contract development and manufacturing organization market is categorized into pharmaceutical companies, biopharmaceutical companies, and others. The biopharmaceutical companies segment dominated the market in 2024.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market: Competitive Landscape and Key Developments

WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Lonza Group AG, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, FUJIFILM Holdings Corp, Pluri Inc, SK pharmteco Inc, Aenova Holding GmbH, and Minaris Advanced Therapies are among the key companies operating in the cell and gene therapy contract development and manufacturing organization market.

Statistics Canada, World Population Prospectus, Globocan, Brazilian Health Regulatory Agency (ANVISA), Alliance for Regenerative Medicine (ARM), and the Food and Drug Administration (FDA) are among the primary and secondary sources referred to while preparing the cell and gene therapy contract development and manufacturing organization market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Landscape

  • 4.1 Overview
  • 4.2 Global Plasmid Manufacturing Market

5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics

  • 5.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Clinical Trials for Innovative Therapies
    • 5.2.2 Surging Regulatory Approvals and Commercialization
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Complexities
  • 5.4 Market Opportunities
    • 5.4.1 Access to Specialized Facilities and Technologies
  • 5.5 Future Trends
    • 5.5.1 Rising Integration of AI and Digital Transformation
  • 5.6 Impact of Drivers and Restraints:

6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Global Market Analysis

  • 6.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • 6.2 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Forecast Analysis

7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Service Type

  • 7.1 Drug Development and Manufacturing
    • 7.1.1 Overview
    • 7.1.2 Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Testing and Regulatory Services
    • 7.2.1 Overview
    • 7.2.2 Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Others
    • 7.3.1 Overview
    • 7.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Product Type

  • 8.1 Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Cell Therapy
    • 8.2.1 Overview
    • 8.2.2 Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.2.2.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.2.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.2.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.2.1 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.2.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.2.3 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.3.1 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.3.2 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.4 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.4.1 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.4.2 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.4.3 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.3.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.3.2.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.3.2.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.3.2.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.3.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.2.1 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.2.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.2.3 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.3.1 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.3.2 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.4 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.4.1 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.4.2 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.4.3 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.5 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.5.1 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.5.2 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.5.3 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.6 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.6.1 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.6.2 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.6.3 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.7 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.7.1 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.7.2 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.7.3 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.4.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.4.2.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.4.2.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.4.2.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.4.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.2.1 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.2.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.2.3 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.3.1 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.3.2 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.4 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.4.1 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.4.2 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.4.3 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.5 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.5.1 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.5.2 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.5.3 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.6 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.6.1 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.6.2 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.6.3 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.7 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.7.1 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.7.2 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.7.3 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.5.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.5.2.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.5.2.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.5.2.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.5.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.2.1 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.2.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.2.3 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.3.1 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.3.2 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.4 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.4.1 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.4.2 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.4.3 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.5 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.5.1 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.5.2 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.5.3 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.6.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.6.2.1 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.6.2.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.6.2.3 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
      • 10.6.2.4 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.6.2.5 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.5.1 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.5.2 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.5.3 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.6 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.6.1 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.6.2 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.6.3 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.7 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.7.1 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.7.2 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.7.3 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Global Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Expansion
  • 12.3 New Product Development
  • 12.4 Merger and Acquisition
  • 12.5 Partnerships
  • 12.6 Other Business Strategies

13. Company Profiles

  • 13.1 WuXi Biologics Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Charles River Laboratories International Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Catalent Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Lonza Group AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 FUJIFILM Holdings Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pluri Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 SK pharmteco Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Aenova Holding GmbH
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Minaris Advanced Therapies
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms
  • 14.2 About The Insight Partners

List Of Tables

  • Table 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation
  • Table 2. Global Plasmid Manufacturing Market, US$ Million, 2021-2031
  • Table 3. Global Plasmid Manufacturing Market, By Type, 2021-2031 (US$ Million)
  • Table 4. Global Plasmid Manufacturing Market, By Application, 2021-2031 (US$ Million)
  • Table 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million)
  • Table 6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million)
  • Table 7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 11. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 13. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 14. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 15. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 16. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 19. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 20. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 21. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 22. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 23. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 24. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 25. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 26. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 27. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 28. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 29. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 30. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 31. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 32. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 33. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 34. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 35. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 36. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 37. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 38. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 39. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 40. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 41. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 42. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 43. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 44. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 45. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 46. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 47. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 48. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 49. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 50. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 51. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 52. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 53. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 54. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 55. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 56. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 57. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 58. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 59. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 60. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 61. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 62. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 63. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 64. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 65. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 66. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 67. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 68. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 69. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 70. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 71. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 72. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 73. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 74. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 75. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 76. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 77. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 78. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 79. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 80. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 81. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 82. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 83. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 84. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 85. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 86. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 87. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 88. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 89. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 90. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 91. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 92. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 93. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 94. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 95. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 96. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 97. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 98. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 99. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 100. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 101. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 102. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 103. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 104. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 105. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 106. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 107. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 108. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 109. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 110. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 111. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 112. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 113. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 114. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 115. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 116. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 117. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 118. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 119. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 120. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 121. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 122. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 123. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 124. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 125. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 126. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 127. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 128. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 129. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 130. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 131. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 132. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 133. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 134. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 135. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 136. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 137. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 138. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 139. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 140. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 141. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 142. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 143. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 144. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 145. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 146. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 147. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 148. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 149. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 150. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 151. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 152. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 154. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 155. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 156. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 157. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 158. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 159. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 160. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 161. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 162. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 163. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 164. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 165. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 166. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 167. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 168. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 169. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 170. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 171. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 172. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 173. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 174. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 175. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 176. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 177. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 178. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 180. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 181. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 182. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 183. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 184. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User

List Of Figures

  • Figure 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • Figure 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Service Type (2024 and 2031)
  • Figure 6. Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Product Type (2024 and 2031)
  • Figure 10. Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 20. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 21. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 22. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 23. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 24. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 25. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 26. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 27. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 28. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 29. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 30. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 31. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 33. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 34. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 35. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 37. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 38. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 39. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 40. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 47. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 48. Global Company Market Share Analysis, 2024